文献速递青光眼眼底病与葡萄膜炎

青光眼患者视乳头旁脉络膜微血管 dropout 与视网膜神经纤维层进行性变薄的评估

Evaluation of Parapapillary Choroidal Microvasculature Dropout and Progressive Retinal Nerve Fiber Layer Thinning in Patients With Glaucoma.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

这项前瞻性观察性病例系列在韩国三级转诊中心纳入68例有视乳头旁脉络膜微血管 dropout 的原发性开角型青光眼患者,随访平均2.5年,用 OCTA 两次测量 dropout 面积、系列 OCT 测量 RNFL 厚度。22眼(32.4%)dropout 面积增加,且 dropout 面积增加越大与整体 RNFL 变薄越快相关(β=-4.74;95%CI,-7.72至-1.75;P=.002)。

要点

  • 68眼中22眼(32.4%)随访期间视乳头旁脉络膜微血管 dropout 面积增加。
  • dropout 面积增加越大与整体 RNFL 变薄越快相关(β=-4.74;95%CI,-7.72至-1.75;P=.002)。
  • 基线或最终随访时的 dropout 面积与 RNFL 变薄速率无关。

核心结论

  • 视乳头旁脉络膜微血管 dropout 扩大与原发性开角型青光眼的进行性 RNFL 变薄相关。

研究设计与样本

  • 前瞻性观察性病例系列,在韩国一家三级转诊中心开展,纳入68例视乳头旁脉络膜微血管 dropout 的原发性开角型青光眼患者,来自正在进行的 Investigating Glaucoma Progression Study,入组时间为2016年1月1日至2018年7月31日。
  • 平均(SD)随访期为2.5(0.2)年,OCTA 图像间隔至少2年获取两次,期间系列 OCT 检查测量 RNFL 厚度至少4次;测量者对参与者临床特征设盲。

主要发现

  • 68名韩国参与者中37名(54.5%)为女性,平均(SD)年龄为54.3(13.1)岁。
  • 68眼中22眼(32.4%)在随访期间显示微血管 dropout 面积增加。
  • 整体 RNFL 变薄更快与基线视乳头旁萎缩 β 区更大相关(β=-0.55;95%CI,-0.96至-0.14;P=.01)。
  • 整体 RNFL 变薄更快与随访期间检出盘沿出血相关(β=-0.75;95%CI,-1.67至-0.34;P=.001)。
  • 整体 RNFL 变薄更快与微血管 dropout 面积增加更大相关(β=-4.74;95%CI,-7.72至-1.75;P=.002)。

关键数值与推荐

  • 微血管 dropout 定义为在脉络膜层中局灶性扇形毛细血管 dropout 且无可见微血管网络。
  • 微血管 dropout 面积变化的意义用95% Bland-Altman 一致性界限界定。
  • RNFL 变薄速率由系列 OCT RNFL 厚度测量的线性回归确定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Parapapillary choroidal microvasculature dropout (MvD) is considered one of pathophysiological manifestations of glaucomatous damage. OBJECTIVE: To evaluate the longitudinal change in the parapapillary choroidal MvD in patients with primary open-angle glaucoma (POAG), and to determine whether this change is associated with progressive retinal nerve fiber layer (RNFL) thinning. DESIGN, SETTING, AND PARTICIPANTS: This prospective observational case series was conducted at a tertiary referral center in Korea and included 68 patients with POAG who exhibited parapapillary choroidal MvD in en face optical coherence tomography (OCT) angiography (OCTA) images who were enrolled from the ongoing Investigating Glaucoma Progression Study from January 1, 2016, through July 31, 2018. The mean (SD) follow-up period was 2.5 (0.2) years and observers were masked to the clinical characteristics of the participants for measurements. The OCTA images were obtained twice at an interval of at least 2 years, during which the RNFL thickness was measured at least 4 times in serial OCT examinations. Microvasculature dropout was defined as a focal sectoral capillary dropout with no visible microvascular network identified in the choroidal layer. The MvD area was measured in the OCTA images obtained at the baseline and the final follow-up. The significance of changes in the MvD area was defined using the 95% Bland-Altman limits of agreement. The rate of RNFL thinning was determined by linear regression of the serial OCT RNFL thickness measurements. MAIN OUTCOMES AND MEASURES: The association between the change in the MvD area and the rate of RNFL thinning. RESULTS: Of 68 Korean participants, 37 (54.5%) were women, and the mean (SD) age was 54.3 (13.1) years. Among 68 eyes, 22 (32.4%) showed increases in the MvD area during the follow-up. Faster global RNFL thinning was associated with a larger baseline parapapillary atrophy β-zone (β = -0.55; 95% CI, -0.96 to -0.14; P = .01), disc hemorrhage detection during the follow-up period (β = -0.75; 95% CI, -1.67 to -0.34; P = .001), and a larger increase in the MvD area (β = -4.74; 95% CI, -7.72 to -1.75; P = .002). The MvD area was not associated with the rate of RNFL thinning at baseline or the final follow-up. CONCLUSIONS AND RELEVANCE: Microvasculature dropout enlargement was associated with progressive RNFL thinning in POAG.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kim JA, Lee EJ, Kim TW, et al. Evaluation of Parapapillary Choroidal Microvasculature Dropout and Progressive Retinal Nerve Fiber Layer Thinning in Patients With Glaucoma. JAMA Ophthalmol. 2019. PMID: 31120486. doi:10.1001/jamaophthalmol.2019.1212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。